NeoGenomics (NASDAQ:NEO) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. This is a 66.67 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $202.000 million which beat the analyst consensus estimate of $196.997 million by 2.54 percent. This is a 11.40 percent increase over sales of $181.330 million the same period last year.